Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1986 Oct;22(4):495–496. doi: 10.1111/j.1365-2125.1986.tb02925.x

Comparative effects of famotidine and cimetidine on 7-ethoxycoumarin O-deethylase activity in human livers.

Y Imai, M Inada, S Tamura, S Kawata, Y Minami, S Tarui
PMCID: PMC1401159  PMID: 3490271

Full text

PDF
495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grahnén A., von Bahr C., Lindström B., Rosén A. Bioavailability and pharmacokinetics of cimetidine. Eur J Clin Pharmacol. 1979 Nov;16(5):335–340. doi: 10.1007/BF00605632. [DOI] [PubMed] [Google Scholar]
  2. Greenlee W. F., Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Pharmacol Exp Ther. 1978 Jun;205(3):596–605. [PubMed] [Google Scholar]
  3. Puurunen J., Sotaniemi E., Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol. 1980 Aug;18(2):185–187. doi: 10.1007/BF00561588. [DOI] [PubMed] [Google Scholar]
  4. Rendić S., Kajfez F., Ruf H. H. Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. Drug Metab Dispos. 1983 Mar-Apr;11(2):137–142. [PubMed] [Google Scholar]
  5. Serlin M. J., Sibeon R. G., Mossman S., Breckenridge A. M., Williams J. R., Atwood J. L., Willoughby J. M. Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979 Aug 18;2(8138):317–319. doi: 10.1016/s0140-6736(79)90340-4. [DOI] [PubMed] [Google Scholar]
  6. Staiger C., Korodnay B., Devries J. X., Weber E., Müller P., Simon B., Dammann H. G. Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers. Br J Clin Pharmacol. 1984 Jul;18(1):105–106. doi: 10.1111/j.1365-2125.1984.tb05031.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Takagi T., Takeda M., Maeno H. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. Arch Int Pharmacodyn Ther. 1982 Mar;256(1):49–58. [PubMed] [Google Scholar]
  8. Walkenstein S. S., Dubb J. W., Randolph W. C., Westlake W. J., Stote R. M., Intoccia A. P. Bioavailability of cimetidine in man. Gastroenterology. 1978 Feb;74(2 Pt 2):360–365. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES